These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31353773)

  • 1. Reply-Letter to the editor.
    Takala SJ; Heikkilä P; Nevanlinna H; Blomqvist C; Mattson J
    Breast J; 2019 Nov; 25(6):1332. PubMed ID: 31353773
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to editor/comment.
    Vranic S
    Breast J; 2019 Nov; 25(6):1330-1331. PubMed ID: 31353784
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to letter to the editor.
    León X
    Head Neck; 2014 Sep; 36(9):1376. PubMed ID: 24797670
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Dr Altundag from the authors of 'Management of breast cancer brain metastases; a practical review'.
    Phillips C; Jeffree R; Khasraw M
    Breast; 2017 Aug; 34():133. PubMed ID: 27955975
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to the letter to the editor 'A centralised multidisciplinary clinic approach for germ cell tumours' by Crawford.
    Albany C; Adra N; Snavely A; Cary C; Masterson T; Foster R; Kesler K; Ulbright T; Cheng L; Chovanec M; Taza F; Hanna N; Einhorn L
    Ann Oncol; 2018 Nov; 29(11):2264-2265. PubMed ID: 30307469
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to "Letter to the Editor" intent of surgery of the primary tumor in metastatic breast cancer remains palliative.
    Vohra NA; Brinkley J; Kachare S; Muzaffar M
    Breast J; 2019 Mar; 25(2):354-355. PubMed ID: 30761703
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Roberto Iacovelli, Walter Artibani, and Giampaolo Tortora's Letter to the Editor re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category. Eur Urol 2017;71:970-8.
    Davis ID; Pezaro C; Xie W; Choueiri TK; Heng DYC
    Eur Urol; 2017 Jun; 71(6):e177-e178. PubMed ID: 28041718
    [No Abstract]   [Full Text] [Related]  

  • 8. Checkpoint inhibition: protecting against or predisposing for second primary tumors? Reply to the Letter to the Editor 'Checkpoint inhibition: protecting against or predisposing for second primary tumors?' by K. P. M. Suijkerbuijk, A. M. May and M. J. M. van Eijs.
    Heudel P; Chabaud S; Perol D; Ray-Coquard I; Blay JY
    Ann Oncol; 2021 Aug; 32(8):1055-1057. PubMed ID: 33932506
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "letter to the editor concerning the article-Impact of surgery on survival in stage IV breast cancer".
    Al Johani B; Al Malik O; Anwar E; Tulbah A; Alshabanah M; AlSyaed A; Ajarim D; Al-Tweigeri T
    Breast J; 2017 Nov; 23(6):775. PubMed ID: 28481425
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to "Letter to the Editor Concerning the Article-Impact of Surgery on Survival in Stage IV Breast Cancer".
    Al Johani B; Al Malik O; Anwar E; Tulbah A; Alshabanah M; AlSayed A; Ajarim D; Al-Tweigeri T
    Breast J; 2017 Jan; 23(1):119. PubMed ID: 27797125
    [No Abstract]   [Full Text] [Related]  

  • 11. In Reply to the Letter to the Editor Regarding "Does Primary Tumor Resection in Patients with Metastatic Primary Mobile Vertebral Column Sarcoma Improve the Survivals?".
    Matsuoka M; Onodera T; Yokota I; Iwasaki N
    World Neurosurg; 2022 Sep; 165():210. PubMed ID: 36123831
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply Letter to the Editor.
    Hanley BP; Walsh S; O'Leary DP; MacNally SP; Power C; Farrell M; Hill A
    Breast J; 2018 Nov; 24(6):1141. PubMed ID: 30051549
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to the Letter to the Editor "Regarding: Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation with Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy".
    Stecklein SR; Bloom ES
    Pract Radiat Oncol; 2019 Mar; 9(2):60. PubMed ID: 30709648
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic mastectomy and breast cancer-- reply.
    Basu NN; Evans DG; Barr L
    Br J Hosp Med (Lond); 2013 Oct; 74(10):595. PubMed ID: 24273773
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: Letter to the Editor.
    Michaels A; Chung CS; Birdwell RL; Frost EP; Giess CS
    Breast J; 2017 Sep; 23(5):618. PubMed ID: 28675681
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Wilms tumor and breast cancer.
    Dean JB; Dome JS
    Cancer; 2015 Jun; 121(12):2100-1. PubMed ID: 25712509
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Wilms tumor and breast cancer.
    Breslow NE; Peterson SM; Green DM
    Cancer; 2015 Jun; 121(12):2099-100. PubMed ID: 25712075
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to letter to editor: "Intra-operative assessment of excised breast tumour Margins using Clear Edge imaging device".
    Dixon JM
    Eur J Surg Oncol; 2017 Aug; 43(8):1604-1605. PubMed ID: 28318685
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to the letter to editor by Zeki Gokhan Surmeli, M.D.
    Muzaffar M; Brinkley J; Vohra NA
    Breast J; 2018 Nov; 24(6):1146-1147. PubMed ID: 30288857
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Rana Nadeem's Letter to the Editor.
    Vidya R; Masià J; Cawthorn S; Berna G; Bozza F; Gardetto A; Kolacinska A; Dell'Antonia F; Tiengo C; Bassetto F; Caputo GG; Governa M
    Breast J; 2018 Mar; 24(2):225-226. PubMed ID: 28741889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.